Freeline Therapeutics Holdings plc

NasdaqCM:FRLN Rapporto sulle azioni

Cap. di mercato: US$28.3m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Freeline Therapeutics Holdings Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Freeline Therapeutics Holdings has a total shareholder equity of $30.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $49.2M and $19.2M respectively.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

US$0

Debito

Indice di copertura degli interessin/a
ContantiUS$29.45m
Patrimonio nettoUS$30.04m
Totale passivitàUS$19.18m
Totale attivitàUS$49.22m

Aggiornamenti recenti sulla salute finanziaria

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Apr 11
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Dec 20
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Recent updates

Calculating The Intrinsic Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN)

Jul 13
Calculating The Intrinsic Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN)

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Apr 11
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Dec 20
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

We're Keeping An Eye On Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Rate

Aug 30
We're Keeping An Eye On Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Rate

Freeline gains as NEJM publishes long-term data for hemophilia therapy

Jul 21

Is Freeline Therapeutics Holdings (NASDAQ:FRLN) In A Good Position To Invest In Growth?

May 05
Is Freeline Therapeutics Holdings (NASDAQ:FRLN) In A Good Position To Invest In Growth?

Will Freeline Therapeutics Holdings (NASDAQ:FRLN) Spend Its Cash Wisely?

Jan 13
Will Freeline Therapeutics Holdings (NASDAQ:FRLN) Spend Its Cash Wisely?

Companies Like Freeline Therapeutics Holdings (NASDAQ:FRLN) Could Be Quite Risky

Sep 30
Companies Like Freeline Therapeutics Holdings (NASDAQ:FRLN) Could Be Quite Risky

Here's Why We're Watching Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Situation

Jun 03
Here's Why We're Watching Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Situation

What Kind Of Shareholders Hold The Majority In Freeline Therapeutics Holdings plc's (NASDAQ:FRLN) Shares?

Feb 18
What Kind Of Shareholders Hold The Majority In Freeline Therapeutics Holdings plc's (NASDAQ:FRLN) Shares?

Analisi della posizione finanziaria

Passività a breve termine: FRLN's short term assets ($34.0M) exceed its short term liabilities ($17.5M).

Passività a lungo termine: FRLN's short term assets ($34.0M) exceed its long term liabilities ($1.7M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: FRLN is debt free.

Riduzione del debito: FRLN has not had any debt for past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: FRLN has less than a year of cash runway based on its current free cash flow.

Previsione Cash Runway: Insufficient data to determine if FRLN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Scoprire le aziende sane